Advanced Search

National Health (Chemotherapy Pharmaceuticals Access Program) Special Arrangement Amendment Instrument 2011 (No. 3) (No. PB 29 of 2011)

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.
 
PB 29 of 2011
National Health (Chemotherapy Pharmaceuticals Access Program) Special Arrangement Amendment Instrument 2011 (No. 3)
 
National Health Act 1953
___________________________________________________________________________
 
I, LINDA JACKSON, Assistant Secretary, Access and Systems Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under subsections 100(1) and (2) of the National Health Act 1953.
Dated   28 March 2011
 
 
 
 
 
 
 
 
 
 
 
LINDA JACKSON
Assistant Secretary
Access and Systems Branch
Pharmaceutical Benefits Division
Department of Health and Ageing
___________________________________________________________________
 
 
 
 
 
1              Name of Instrument
 
(1)                This Instrument is the National Health (Chemotherapy Pharmaceuticals Access Program) Special Arrangement Amendment Instrument 2011 (No.3).
 
(2)                This Instrument may also be cited as PB 29 of 2011.
 
2                Commencement
                            This Instrument commences on 1 April 2011.
3              Amendments to PB 117 of 2010
                       Schedule 1 amends the National Health (Chemotherapy Pharmaceuticals  Access Program) Special Arrangement 2010 (PB 117 of 2010).
.
 
Schedule 1                   Amendments
 
[1]   Schedule 1, entry for Epirubicin in the form Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL:
substitute:

 
Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL
Injection/ intravesical
DBL Epirubicin Hydrochloride Injection
HH
EMP
 
 
1
0
 

 
 
 
Epirubicin Ebewe
IT
EMP
 
 
1
0
 

 
[2]   Schedule 1, entry for Idarubicin:
substitute:

Idarubicin
Solution for I.V. injection containing idarubicin hydrochloride 5 mg in 5 mL
Injection
Idarubicin Ebewe
IT
EMP
C1006
 
3
0
 

 
 
 
Zavedos Solution
PF
EMP
C1006
 
3
0
 

 
Solution for I.V. injection containing idarubicin hydrochloride 10 mg in 10 mL
Injection
Idarubicin Ebewe
IT
EMP
C1006
 
6
0
 

 
 
 
Zavedos Solution
PF
EMP
C1006
 
6
0
 

 
 
Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. 
See http://www.frli.gov.au.